We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Blue Light Therapy Helps Recovery from Mild TBI

By HospiMedica International staff writers
Posted on 27 Jan 2020
A new study suggests that exposing the retinohypothalamic system in the eye to blue light can assist mild traumatic brain injury (mTBI) recovery.

Researchers at the University of Arizona (Tucson, USA) conducted a randomized, double-blind, placebo-controlled trial of 32 adults (18–48 years of age) recovering from a recent mTBI. More...
The researchers compared of cumulative six weeks of daily 30-minute pulses of blue light (469 nm) each morning to an amber (578 nm) placebo light on neurocognitive and neuroimaging outcomes, including gray matter volume (GMV), resting-state functional connectivity, directed connectivity using Granger causality, and white matter integrity using diffusion tensor imaging (DTI).

According to the researchers, blue light suppresses brain production of melatonin. Exposure to blue light in the morning shifts the brain's biological clock so that is produced earlier, aligning it with the natural circadian rhythm. The results showed that relative to placebo, morning blue light led to phase-advanced sleep timing, reduced daytime sleepiness, higher executive functioning, increased GMV of the posterior thalamus, greater thalamo-cortical functional connectivity, and increased axonal integrity. The study was published in the February 2020 issue of Neurobiology of Disease.

“The circadian rhythm is one of the most powerful influences on human behavior. Daily exposure to blue wavelength light each morning helps to re-entrain the circadian rhythm so that people get better, more regular sleep. This is likely true for everybody, but we recently demonstrated it in people recovering from mTBI,” said lead author Professor William Killgore, MD. “That improvement in sleep was translated into improvements in cognitive function, reduced daytime sleepiness, and actual brain repair.”

Melatonin, discovered in 1958, is a hormone released by the pineal gland that regulates the sleep–wake cycle. It is involved in synchronization of the circadian rhythm, including sleep-wake timing and blood pressure regulation. For most animals, the timing of sleep and wakefulness is in synch with the circadian control of the sleep cycle and all other circadian-controlled rhythms. Humans, on the other hand, have the unique ability to cognitively override their internal biological clock and its rhythmic outputs.

Related Links:
University of Arizona


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Enteral Feeding Pump
Instilar 1420
New
Anesthetic Gas Measurement Module
Scio Four
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.